These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29085781)

  • 1. Dietary management of maternal phenylketonuria with glycomacropeptide and amino acids supplements: A case report.
    Pinto A; Almeida MF; Cunha A; Carmona C; Rocha S; Guimas A; Ribeiro R; Mota CR; Martins E; MacDonald A; Rocha JC
    Mol Genet Metab Rep; 2017 Dec; 13():105-110. PubMed ID: 29085781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nutritional status in patients with phenylketonuria using glycomacropeptide as their major protein source.
    Pinto A; Almeida MF; Ramos PC; Rocha S; Guimas A; Ribeiro R; Martins E; Bandeira A; MacDonald A; Rocha JC
    Eur J Clin Nutr; 2017 Oct; 71(10):1230-1234. PubMed ID: 28402322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycomacropeptide: long-term use and impact on blood phenylalanine, growth and nutritional status in children with PKU.
    Daly A; Evans S; Chahal S; Santra S; Pinto A; Jackson R; Gingell C; Rocha J; Van Spronsen FJ; MacDonald A
    Orphanet J Rare Dis; 2019 Feb; 14(1):44. PubMed ID: 30770754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effect of Glycomacropeptide versus Amino Acids on Phenylalanine and Tyrosine Variability over 24 Hours in Children with PKU: A Randomized Controlled Trial.
    Daly A; Evans S; Chahal S; Santra S; Pinto A; Gingell C; Rocha JC; van Spronsen F; Jackson R; MacDonald A
    Nutrients; 2019 Feb; 11(3):. PubMed ID: 30823411
    [No Abstract]   [Full Text] [Related]  

  • 5. Glycomacropeptide in children with phenylketonuria: does its phenylalanine content affect blood phenylalanine control?
    Daly A; Evans S; Chahal S; Santra S; MacDonald A
    J Hum Nutr Diet; 2017 Aug; 30(4):515-523. PubMed ID: 28111827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycomacropeptide for nutritional management of phenylketonuria: a randomized, controlled, crossover trial.
    Ney DM; Stroup BM; Clayton MK; Murali SG; Rice GM; Rohr F; Levy HL
    Am J Clin Nutr; 2016 Aug; 104(2):334-45. PubMed ID: 27413125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Casein Glycomacropeptide: An Alternative Protein Substitute in Tyrosinemia Type I.
    Daly A; Evans S; Pinto A; Ashmore C; MacDonald A
    Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The maternal phenylketonuria syndrom--still current problem].
    Didycz B; Domagała L; Pietrzyk JJ
    Przegl Lek; 2009; 66(1-2):4-10. PubMed ID: 19485248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal Dietary Intake Data in Patients with Phenylketonuria from Europe: The Impact of Age and Phenylketonuria Severity.
    Pinto A; Ahring K; Almeida MF; Ashmore C; Bélanger-Quintana A; Burlina A; Coşkun T; Daly A; van Dam E; Dursun A; Evans S; Feillet F; Giżewska M; Gökmen-Özel H; Hickson M; Hoekstra Y; Ilgaz F; Jackson R; Leśniak A; Loro C; Malicka K; Patalan M; Rocha JC; Sivri S; Rodenburg I; van Spronsen F; Strączek K; Tokatli A; MacDonald A
    Nutrients; 2024 Aug; 16(17):. PubMed ID: 39275225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nutritional management of PKU with glycomacropeptide from cheese whey.
    Ney DM; Gleason ST; van Calcar SC; MacLeod EL; Nelson KL; Etzel MR; Rice GM; Wolff JA
    J Inherit Metab Dis; 2009 Feb; 32(1):32-9. PubMed ID: 18956251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary Investigation to Review If a Glycomacropeptide Compared to L-Amino Acid Protein Substitute Alters the Pre- and Postprandial Amino Acid Profile in Children with Phenylketonuria.
    Daly A; Evans S; Pinto A; Jackson R; Ashmore C; Rocha JC; MacDonald A
    Nutrients; 2020 Aug; 12(8):. PubMed ID: 32823853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal Phenylketonuria International Collaborative Study revisited: evaluation of maternal nutritional risk factors besides phenylalanine for fetal congenital heart defects.
    Yano S; Moseley K; Bottiglieri T; Arning E; Azen C
    J Inherit Metab Dis; 2014 Jan; 37(1):39-42. PubMed ID: 23784316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of phenylalanine levels during pregnancy on birth weight and later development in children born to women with phenylketonuria.
    Nielsen MR; Jørgensen C; Ahring K; Lund AM; Ørngreen MC
    J Inherit Metab Dis; 2023 Jul; 46(4):586-594. PubMed ID: 36843352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of nutrition in pregnancy with phenylketonuria and birth defects.
    Matalon KM; Acosta PB; Azen C
    Pediatrics; 2003 Dec; 112(6 Pt 2):1534-6. PubMed ID: 14654660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein requirements in adults with phenylketonuria and bioavailability of glycomacropeptide compared to an l-amino acid-based product.
    Turki A; Stockler-Ipsiroglu S; Sirrs S; Branov J; Bosdet T; Elango R
    J Inherit Metab Dis; 2024 Oct; ():. PubMed ID: 39410795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancy in phenylketonuria: dietary treatment aimed at normalising maternal plasma phenylalanine concentration.
    Thompson GN; Francis DE; Kirby DM; Compton R
    Arch Dis Child; 1991 Nov; 66(11):1346-9. PubMed ID: 1755650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous use of glycomacropeptide in the nutritional management of patients with phenylketonuria: a clinical perspective.
    Pena MJ; Pinto A; de Almeida MF; de Sousa Barbosa C; Ramos PC; Rocha S; Guimas A; Ribeiro R; Martins E; Bandeira A; Dias CC; MacDonald A; Borges N; Rocha JC
    Orphanet J Rare Dis; 2021 Feb; 16(1):84. PubMed ID: 33581730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Use of Glycomacropeptide in Patients with Phenylketonuria: A Systematic Review and Meta-Analysis.
    Pena MJ; Pinto A; Daly A; MacDonald A; Azevedo L; Rocha JC; Borges N
    Nutrients; 2018 Nov; 10(11):. PubMed ID: 30453665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Born at 27 weeks of gestation with classical PKU: challenges of dietetic management in a very preterm infant.
    Ballhausen D; Egli D; Bickle-Graz M; Bianchi N; Bonafé L
    Pediatr Rep; 2011 Sep; 3(4):e26. PubMed ID: 22355511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of paediatric PKU breath malodour, comparing glycomacropeptide with phenylalanine free L-amino acid supplements.
    Tiele A; Daly A; Hattersley J; Pinto A; Evans S; Ashmore C; MacDonald A; Covington JA
    J Breath Res; 2019 Oct; 14(1):016001. PubMed ID: 31476741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.